AI Stock Analysis - Pfizer (PFE)
Analysis generated January 9, 2026.
Pfizer Inc. (NYSE: PFE) is a global pharmaceutical corporation specializing in the development and production of medications and vaccines. With a rich history dating back to 1849, Pfizer has established itself as a leader in innovative healthcare solutions. The company’s portfolio includes some of the world's best-selling medicines and vaccines, including prominent products like the COVID-19 vaccine developed in partnership with BioNTech.
Stock Alerts - Pfizer (PFE)
 |
Pfizer | January 26 James French Hill (member of U.S. congress) is selling shares |
|
Pfizer | January 23 Reddit mentions are up by 103% in the last 24h. |
|
Pfizer | January 22 Job postings are up by 27.4% in the last couple of days. |
|
Pfizer | January 21 Reddit mentions are up by 107% in the last 24h. |
Download our app to get future alerts delivered in real-time.
Alternative Data for Pfizer
About Pfizer
Pfizer Inc is a biopharmaceutical company that discovers, develops, manufactures, and markets healthcare products including medicines, and vaccines as well as many of the consumer healthcare products.
| Price | $26.50 |
| Target Price | Sign up |
| Volume | 74,190,000 |
| Market Cap | $146B |
| Year Range | $22.26 - $26.9 |
| Dividend Yield | 6.62% |
| PE Ratio | 14.91 |
| Analyst Rating | 42% buy |
| Earnings Date | February 3 '26 |
| Industry | Drug Manufacturers |
In the news
 |
Pfizer’s CEO on leading after a moonshot—and making deals with TrumpJanuary 27 - Fortune |
 |
Pfizer to Exit ViiV Healthcare as GSK and Shionogi Reshape OwnershipJanuary 25 - Yahoo Entertainment |
 |
Mixed options sentiment in Pfizer with shareslittle changedJanuary 23 - Thefly.com |
 |
Pfizer: Expect Another Double Beating For Q1 (Earnings Preview)January 22 - SeekingAlpha |
 |
Will Licensing Novavax’s Matrix-M Adjuvant Reshape Pfizer’s (PFE) Vaccine Platform Strategy?January 22 - Yahoo |
Is Pfizer an Absurdly Cheap Dividend Stock, or Just a Value Trap?January 22 - Yahoo Entertainment |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 16.7B | 4.17B | 12.5B | 3.54B | 5.65B | 0.870 |
| Q2 '25 | 14.7B | 5.23B | 9.42B | 2.91B | 5.32B | 0.510 |
| Q1 '25 | 13.7B | 3.89B | 9.83B | 2.97B | 5.06B | 0.920 |
| Q4 '24 | 17.8B | 4.8B | 13B | 403M | 5.14B | 0.630 |
| Q3 '24 | 17.7B | 6.93B | 10.8B | 4.47B | 7.25B | 1.060 |
Insider Transactions View All
| DAMICO JENNIFER B. filed to sell 11,850 shares at $25.9. March 6 '25 |
| BLAYLOCK RONALD E filed to buy 27,707 shares at $25.7. February 14 '25 |
| Gottlieb Scott filed to buy 10,000 shares at $28.2. October 31 '24 |
| DAMICO JENNIFER B. filed to sell 8,582 shares at $28.7. August 14 '24 |
| Gottlieb Scott filed to buy 9,000 shares at $26.5. December 19 '23 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| James French Hill |
Jan 26, 26 | Sell | $100K - $250K |
| Gilbert Cisneros |
Jan 13, 26 | Sell | $1K - $15K |
| Lisa McClain |
Aug 13, 25 | Buy | $1K - $15K |
Read more about Pfizer (PFE) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
FAQ - Pfizer
The Market Cap of Pfizer is $146B.
As of today, Pfizer's PE (Price to Earnings) ratio is 14.91.
Pfizer will report its next earnings on February 3 '26.
Currently, the price of one share of Pfizer stock is $26.50.
The PFE stock price chart above provides a comprehensive visual representation of Pfizer's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Pfizer shares. Our platform offers an up-to-date PFE stock price chart, along with technical data analysis and alternative data insights.
Yes, Pfizer (PFE) offers dividends to its shareholders, with a dividend yield of 6.62%. This dividend yield represents Pfizer's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Pfizer in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
Some of the similar stocks of Pfizer are Johnson & Johnson, Eli Lilly and Company, Astrazeneca, AbbVie, and TherapeuticsMD.
